101 related articles for article (PubMed ID: 27885695)
1. Vaccination mitigates the impact of PRRSv infection on the pharmacokinetics of ceftiofur crystalline-free acid in pigs.
Sparks JW; Karriker LA; Day DN; Wulf LW; Zhang J; Stock ML; Bates JL; Gehring R; Coetzee JF
J Vet Pharmacol Ther; 2017 Aug; 40(4):363-369. PubMed ID: 27885695
[TBL] [Abstract][Full Text] [Related]
2. Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.
Jeong J; Kim S; Park C; Park KH; Kang I; Park SJ; Chae C
Vet Rec; 2018 Apr; 182(17):485. PubMed ID: 29472439
[TBL] [Abstract][Full Text] [Related]
3. Comparison of virus detection, productivity, and economic performance between lots of growing pigs vaccinated with two doses or one dose of PRRS MLV vaccine, under field conditions.
Moura CAA; Philips R; Silva GS; Holtkamp DJ; Linhares DCL
Prev Vet Med; 2022 Jul; 204():105669. PubMed ID: 35594607
[TBL] [Abstract][Full Text] [Related]
4. Effect of a major quantitative trait locus for porcine reproductive and respiratory syndrome (PRRS) resistance on response to coinfection with PRRS virus and porcine circovirus type 2b (PCV2b) in commercial pigs, with or without prior vaccination for PRRS.
Dunkelberger JR; Serão NV; Niederwerder MC; Kerrigan MA; Lunney JK; Rowland RR; Dekkers JC
J Anim Sci; 2017 Feb; 95(2):584-598. PubMed ID: 28380604
[TBL] [Abstract][Full Text] [Related]
5. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
Zhang Z; Wang Y; Fan H; Lu C
Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
[TBL] [Abstract][Full Text] [Related]
6. Examination of viraemia and clinical signs after challenge with a heterologous PRRSV strain in PRRS Type 2 MLV vaccinated pigs: A challenge-dose study.
Haiwick G; Hermann J; Roof M; Fergen B; Philips R; Patterson A
PLoS One; 2018; 13(12):e0209784. PubMed ID: 30592764
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.
Niederwerder MC; Bawa B; Serão NV; Trible BR; Kerrigan MA; Lunney JK; Dekkers JC; Rowland RR
Clin Vaccine Immunol; 2015 Dec; 22(12):1244-54. PubMed ID: 26446422
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of antimicrobial treatments and vaccination regimens for control of porcine reproductive and respiratory syndrome virus and Streptococcus suis coinfection of nursery pigs.
Halbur P; Thanawongnuwech R; Brown G; Kinyon J; Roth J; Thacker E; Thacker B
J Clin Microbiol; 2000 Mar; 38(3):1156-60. PubMed ID: 10699012
[TBL] [Abstract][Full Text] [Related]
10. Impact of an experimental PRRSV and Streptococcus suis coinfection on the pharmacokinetics of ceftiofur hydrochloride after intramuscular injection in pigs.
Day DN; Sparks JW; Karriker LA; Stalder KJ; Wulf LW; Zhang J; Kinyon JM; Stock ML; Gehring R; Wang C; Ellingson J; Coetzee JF
J Vet Pharmacol Ther; 2015 Oct; 38(5):475-81. PubMed ID: 25689130
[TBL] [Abstract][Full Text] [Related]
11. Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine.
Opriessnig T; McKeown NE; Harmon KL; Meng XJ; Halbur PG
Clin Vaccine Immunol; 2006 Aug; 13(8):923-9. PubMed ID: 16893993
[TBL] [Abstract][Full Text] [Related]
12. Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.
Park C; Choi K; Jeong J; Chae C
Vet Microbiol; 2015 May; 177(1-2):87-94. PubMed ID: 25769646
[TBL] [Abstract][Full Text] [Related]
13. Reproductive, productivity, and mortality outcomes in late-gestation gilts and their litters following simulation of inadvertent exposure to a modified-live vaccine strain of porcine reproductive and respiratory syndrome (PRRS) virus.
Schelkopf A; Nerem J; Cowles B; Amodie D; Swalla R; Dee S
Vaccine; 2014 Aug; 32(36):4639-43. PubMed ID: 24975816
[TBL] [Abstract][Full Text] [Related]
14. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
[TBL] [Abstract][Full Text] [Related]
16. Immunization of pigs with a type 2 modified live PRRSV vaccine prevents the development of a deadly long lasting hyperpyrexia in a challenge study with highly pathogenic PRRSV JX143.
Wei Z; Zhang J; Zhuang J; Sun Z; Gao F; Yuan S
Vaccine; 2013 Apr; 31(16):2062-6. PubMed ID: 23422144
[TBL] [Abstract][Full Text] [Related]
17. Dynamics and evolution of porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 following modified live PRRSV vaccination in a PRRSV-infected herd.
Nilubol D; Tripipat T; Hoonsuwan T; Tipsombatboon P; Piriyapongsa J
Arch Virol; 2014 Jan; 159(1):17-27. PubMed ID: 23851653
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a 20year old porcine reproductive and respiratory syndrome (PRRS) modified live vaccine (Ingelvac(®) PRRS MLV) against two recent type 2 PRRS virus isolates in South Korea.
Jeong J; Choi K; Kang I; Park C; Chae C
Vet Microbiol; 2016 Aug; 192():102-109. PubMed ID: 27527771
[TBL] [Abstract][Full Text] [Related]
19. Vaccination against porcine reproductive and respiratory syndrome virus (PRRSV) reduces the magnitude and duration of viremia following challenge with a virulent heterologous field strain.
Calvert JG; Keith ML; Pearce DS; Lenz MC; King VL; Diamondidis YA; Ankenbauer RG; Martinon NC
Vet Microbiol; 2017 Jun; 205():80-83. PubMed ID: 28622868
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
